A detailed history of Red Door Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Red Door Wealth Management, LLC holds 2,045 shares of LLY stock, worth $1.6 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
2,045
Previous 1,921 6.45%
Holding current value
$1.6 Million
Previous $1.74 Million 4.14%
% of portfolio
0.32%
Previous 0.32%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$772.14 - $960.02 $95,745 - $119,042
124 Added 6.45%
2,045 $1.81 Million
Q2 2024

Jul 17, 2024

BUY
$724.87 - $909.04 $68,137 - $85,449
94 Added 5.15%
1,921 $1.74 Million
Q1 2024

Apr 17, 2024

SELL
$592.2 - $792.28 $177,067 - $236,891
-299 Reduced 14.06%
1,827 $1.42 Million
Q4 2023

Jan 17, 2024

BUY
$525.19 - $619.13 $159,132 - $187,596
303 Added 16.62%
2,126 $1.24 Million
Q3 2023

Oct 19, 2023

SELL
$434.7 - $599.3 $96,938 - $133,643
-223 Reduced 10.9%
1,823 $979,000
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $491,737 - $657,509
1,402 Added 217.7%
2,046 $959,000
Q1 2023

May 08, 2023

SELL
$310.63 - $364.82 $22,986 - $26,996
-74 Reduced 10.31%
644 $221,000
Q4 2022

Jan 23, 2023

BUY
$321.55 - $374.67 $964 - $1,124
3 Added 0.42%
718 $0
Q3 2022

Oct 13, 2022

BUY
$296.48 - $337.87 $6,819 - $7,771
23 Added 3.32%
715 $231,000
Q2 2022

Jul 13, 2022

BUY
$278.73 - $327.27 $192,881 - $226,470
692 New
692 $224,000
Q3 2021

Oct 14, 2021

SELL
$221.6 - $272.71 $106,589 - $131,173
-481 Closed
0 $0
Q2 2021

Jul 29, 2021

BUY
$180.55 - $233.54 $86,844 - $112,332
481 New
481 $110,000
Q3 2020

Oct 14, 2020

SELL
$146.22 - $169.13 $70,331 - $81,351
-481 Closed
0 $0
Q1 2020

Apr 20, 2020

BUY
$119.05 - $147.35 $57,263 - $70,875
481 New
481 $66,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Red Door Wealth Management, LLC Portfolio

Follow Red Door Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Door Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Door Wealth Management, LLC with notifications on news.